PepGen Inc. Files 8-K Report
Ticker: PEPG · Form: 8-K · Filed: Mar 4, 2024 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
PepGen filed an 8-K, mostly boilerplate for now.
AI Summary
On March 4, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant disclosures detailed in the provided text. The company is incorporated in Delaware and its principal executive offices are located in Boston, Massachusetts.
Why It Matters
This 8-K filing indicates PepGen Inc. is fulfilling its reporting obligations, though the provided excerpt does not contain specific operational or financial updates.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate material news, suggesting low immediate risk based on this document alone.
Key Numbers
- 001-41374 — SEC File Number (Identifies the company's filing with the SEC.)
- 85-3819886 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PepGen Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for PepGen Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the filing's item information.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 04, 2024.
Where are PepGen Inc.'s principal executive offices located?
PepGen Inc.'s principal executive offices are located at 321 Harrison Avenue 8th Floor, Boston, Massachusetts, 02118.
What is PepGen Inc.'s state of incorporation?
PepGen Inc. is incorporated in Delaware.
What is PepGen Inc.'s telephone number?
PepGen Inc.'s telephone number is (781) 797-0979.
Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-03-04 07:27:05
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share PEPG Nasdaq Global Select
Filing Documents
- pepg-20240304.htm (8-K) — 37KB
- pepg-ex99_1.htm (EX-99.1) — 19KB
- 0000950170-24-024350.txt ( ) — 175KB
- pepg-20240304.xsd (EX-101.SCH) — 25KB
- pepg-20240304_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On March 4, 2024, PepGen Inc. (the "Company") announced clearance of its Clinical Trial Application by the UK Medicines & Healthcare products Regulatory Agency to begin CONNECT2-EDO51, a Phase 2 Clinical Trial. A copy of the press release issued in connection with this announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on March 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: March 4, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief Financial Officer